Introduction {#S1}
============

Our world is now old and aging. Aging population is a long-term trend in Portugal, Europe, and around the World. According to United Nations data from 2015, the number of people over 65 has increased considerably in the largest regions of the world, and this aging is expected to accelerate in the coming decades ([@B1]). The same data point out that, in 2015, 1 in 8 people in the world were 60 years or older, totaling 901 million elderly people. A 176 million of these elderly people live in Europe.

In Portugal, the number of people over 65 years of age doubled in relation to the 1970s and, by 2015, was already over two million, with the population over 80 years old increasing fivefold. In concrete terms, there were 836,058 people aged 65 and over in Portugal in 1971. In 1977, they surpassed one million and, in 2012, two million. In 2015, they were 2,122,996 ([@B2]).

Although the epidemiological investigation has begun to converge regarding the estimation of the prevalence of anxiety and depression in elderly populations, there are still quite a few discrepancies ([@B3]). The sampling procedures diverge greatly: some studies use representative samples from the respective country, and others use samples of convenience. In addition, there is considerable instability in age cutoffs considered for the definition of the elderly or older adult. On the other hand, there is much variation in the operationalization of anxiety and depression, partly due to the use of different evaluation instruments. In fact, some authors consider that anxiety and depression are among the most serious problems faced by modern societies is depression among the elderly ([@B4]). Although depression is fairly common in the last years of life ([@B5]), there is great variation in its prevalence in studies worldwide (9--33%) ([@B6]).

Factors associated with aging, such as social isolation, reduced autonomy, financial insecurity, and poor health, cause an increase in the prevalence of these disorders ([@B7]).

Some studies point to psychosocial risk factors for anxiety disorders and late-onset depression: female gender, cognitive dysfunction, chronic illness, poor health perception, functional limitations, personality traits such as neuroticism and weak coping strategies ([@B8], [@B9]). Specifically, for anxiety disorder: not having children, low income, and experiencing traumatic events ([@B10]).

Given the social and economic context of our country, generating relevant evidence on anxiety and depressive symptoms in the Portuguese elderly population, and understanding them from a point of view that goes beyond the mental illness itself, by approaching the possible associated factors, is crucial. Data on elderly mental health and associated factors could be useful to address therapeutic programs and better planning of health care.

Therefore, to comprehend models of anxiety and depression independently in the Portuguese senior population, this study aims to: (1) determine the prevalence of anxiety and depression symptoms and (2) identify relevant associations between the symptoms of anxiety and depression and chronic self-reported non-communicable diseases, lifestyles, and sociodemographic characteristics.

Materials and Methods {#S2}
=====================

Sample {#S2-1}
------

To analyze the older adult Portuguese population in terms of symptoms of anxiety and depression, their association with non-communicable chronic diseases, function, lifestyles, and quality of life we used data from the second wave of follow-up for EpiDoC Cohort---EpiDoC 2 (CoReumaPt) study---done by computer-assisted telephone interviews (CATIs).

The EpiDoC 2 evaluation consisted on a structured questionnaire, applied through phone call interviews to 10,153 eligible participants of EpiDoC 1 (EpiReumaPt) ([@B11]--[@B13]), a large population-based sample, who consented to be contacted again for follow-up. The study population comprised adults (≥18 years old) living in the community, in Portugal Mainland and Islands (Azores and Madeira). Exclusion criteria were as follows: being resident in institutions and individuals unable to speak Portuguese or to complete the assessment protocol. Participants were selected through a process of multistage random sampling. The sample was stratified by region and population size.

EpiDoC 2 (CoReumaPt) included 7,591 participants, representative of the adult Portuguese population. This study included 1,680 seniors (65 and more years old) of the EpiDoC 2 study, who responded to Hospital Anxiety and Depression Scale (HADS) (Figure [1](#F1){ref-type="fig"}).

![Flowchart describing population eligible for this study.](fmed-04-00196-g001){#F1}

Data Collection {#S2-2}
---------------

Data collection was performed from March 26th 2013 to July 27th 2015. A trained research assistants' team was responsible for collecting the follow-up data from these subjects, by randomly call all the individuals. When a contact was not available, they would hold more attempts in different moments (morning, afternoon, evening, and weekends) to perform six attempts. The last contact had to have at least 1 month of interval from the previous one. Only then the contact would be abandoned. Rescheduling of the telephonic interviews to a more convenient moment was also an option. The interview was telephonically performed with the assistance of a CATI system.

Data were collected in a standardized form, and database access was protected by unique username and password, for each research team member, according to Portuguese Law of data collection ([@B14]).

Measurements, Assessment, and Instruments {#S2-3}
-----------------------------------------

### Case Definition {#S2-3-1}

To evaluate symptoms of anxiety and depression in EpiDoC 2 study, the HADS Portuguese validated version was applied ([@B15]). The HADS was originally developed by Zigmond and Snaith ([@B16]) as a screening tool to apprehend clinically significant states of anxiety and depression in a non-psychiatric hospital setting. Individual anxiety and depression scores were calculated by summation of the appropriate seven items and thus can range from 0 to 21, with higher scores indicating higher levels of anxiety or depression, respectively. In both subscales, a score between 0 and 7 is "normal," between 8 and 10 "mild," between 11 and 14 "moderate," and between 15 and 21 "severe" (idem). Presence of anxiety and depression symptoms was defined when HADS scale was ≥11, since Snaith suggested a score ≥11 was indicative of "caseness" to a mood disorder ([@B17]). We also used the HADS scale as a continuous outcome in the final analyses.

### Sociodemographic and Socioeconomic Characteristics {#S2-3-2}

Information on sociodemographic (sex, age, years of education, household composition, and NUT II), as well as socioeconomic variables (household income), was collected in the first wave---EpiDoC 1 study. Subjects were asked in the EpiDoC 2 study interview whether there have been changes.

### Health Characteristics {#S2-3-3}

In EpiDoC 1 study, individuals were asked if they had been previously diagnosed with some chronic disease (high cholesterol level, high blood pressure, rheumatic disease, allergy, gastrointestinal disease, cardiac disease, diabetes, thyroid and parathyroid disease, urolithiasis, pulmonary disease, hyperuricemia, cancer, neurologic disease, and hypogonadism), and this information was updated in the EpiDoC 2 study interview.

Self-reported height and weight were collected in EpiDoC 2. Based on these data, body mass index (BMI, weight/height^2^, in kg/m^2^) was calculated and categorized according to the World Health Organization classification in four categories: underweight (BMI \< 18.5 kg/m^2^), normal (BMI between 18.5 and 24.9 kg/m^2^), overweight (BMI between 25 and 29.9 kg/m^2^), and obesity (BMI ≥ 30 kg/m^2^) ([@B18]).

Health-related quality of life was assessed using the Portuguese validated version of European Quality of Life questionnaire (EQ-5D-3L) ([@B19], [@B20]).

Function was evaluated based on the Portuguese version of Health Assessment Questionnaire (HAQ) ([@B21], [@B22]).

To assess health-care resources consumption, "number of medical appointments in the previous 12 months" and "hospitalization in the previous 12 months (yes/no)" was asked to participants.

### Lifestyle Characteristics {#S2-3-4}

In EpiDoC 2 study, questions concerning lifestyle habits included frequency of alcohol intake (daily, occasionally, and never), smoking habits (current smoker, past smoker, and never smoked), sleep habits (number of hours of sleep per day, categorized in \<6 and ≥6 h/day). Physical activity level was classified based on the question related to the reported weekly frequency of physical activity. A frequency of once a week or more was considered "yes" to regular physical exercise.

Statistical Analysis {#S2-4}
--------------------

### Sample Weights {#S2-4-1}

EpiDoC was designed to obtain a representative sample of the Portuguese population ([@B13]). To guarantee its representativeness, weighted proportions have, for this matter, been computed and are described elsewhere ([@B13]).

To maintain the representativeness of the sample in relation to the Portuguese population (Mainland and Islands) in the second wave, extrapolation weights were again computed and used in further statistical analysis. These were obtained by calibrating the extrapolation weights originally designed for the EpiDoC 1 study sample. We first compared the participants and non-participants of EpiDoC 2 study, concerning their sociodemographic, socioeconomic and rheumatic disease screening, and health status characteristics. Then, we decided to adjust weights based on the stratification by seven NUTII regions \[Norte, Centro, Lisboa, Alentejo, Algarve, and islands (Azores and Madeira)\], gender (male and female), age categories (18--35, 36--55, 56--65, ≥8--35, 36--55 years old for NUTII Norte, Centro, and Lisboa; 18--65, 66+ for NUTII Alentejo, Algarve, and islands), and rheumatic disease screening (positive/negative).

Analysis and Statistical Software {#S2-5}
---------------------------------

Descriptive data for each categorical variable were presented as the absolute frequency and the correspondent proportion, weighted. The same adjustment has been done for the mean and SD for each continuous variable. Continuous variables were compared using Student's *t*-test or ANOVA, and nominal variables were compared using chi-square test.

To assess the determinants of anxiety and depression symptoms, we first performed univariate analysis to approach relations between independent variables (non-communicable chronic diseases, lifestyles, and sociodemographic characteristics) and outcomes (presence of anxiety and depression symptoms). When univariate analyses resulted in *p*-value \< 0.1, those variables were included into the multivariable logistic regression models. Multivariable models were constructed using a forward selection method. The following independent variables were tested: age, gender, NUTS II, education level (0--4 vs ≥5 years), BMI (underweight, normal, overweight, and obese), alcohol intake (never, daily, and occasionally), current smoking, physical activity (yes/no), and chronic non-communicable diseases---high blood pressure, diabetes, high cholesterol level, pulmonary disease, cardiac disease, neurologic disease, allergies, neoplasic disease, thyroid disease, hyperuricemia, and rheumatic disease. Age, gender, and NUTS II were forced to stay in the model. The goodness of fit of the final multivariable regression model for the outcome anxiety has *p* = 0.287, and the goodness of fit of the final multivariable regression model for the outcome depression has *p* = 0.4.

Significance level was set at 0.05. All analyses were weighted and executed using STATA IC version 12 (StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX, USA: StataCorp LP).

Ethical Issues and Data Protection {#S2-6}
----------------------------------

EpiDoC 1 study was performed following the principles established by the Declaration of Helsinki ([@B23]) and revised in 2013 in Fortaleza. The study was reviewed and approved by the National Committee for Data Protection (Comissão Nacional de Proteção de Dados) and by the NOVA Medical School Ethics Committee. The participants provided informed consent to contribute in all phases of the study.

The EpiDoC 2 study was also approved by National Committee for Data Protection (in accordance with the Portuguese law number 67/98, October 26th, regarding protection of personal data) and was submitted to the same Ethics Committee. The study was conducted in accordance with the applicable laws and regulations including, but not limited to, the Guideline for Good Clinical Practice and the ethical principles stated in the Declaration of Helsinki ([@B23]).

Participants' confidentiality is safeguarded by the nonexistence of identifiers on the database (only unique ID participants' codes). Their names and contacts are stored separately from study data transmitted to the coordinating center. Thus, all data are kept anonymously and securely by the EpiDoC 2 study authorized staff. During EpiDoC 1 study, informed consent was also signed by those accepting to participate in the EpiDoC 2 study. There will be absolutely no disclosure of individual health information to the general public.

Results {#S3}
=======

Our population of interest included 1,680 participants over 64 years old, 908 (54%) of those were females. Forty four percent were 75 years old or more. With respect to educational level, almost two-thirds of participants (*n* = 1,259; 76.03%) had less or equal to 4 years of education.

Most people with 65 years of age and more reported to live on a household income of less than 1,000€ per month; 35.8% reported the lowest income level of 500€/month. Moreover, elderlies tend to live in households are composed by only one (25.53%) or two persons (55.89%).

With respect to health-related characteristics, the observed mean number of non-communicable chronic diseases was 3.10 (±2.1). The most frequently reported chronic diseases were high blood pressure (57.3%), rheumatic diseases (50.53%), and high cholesterol level (49.7%).

People 65+ years old score EQ-5D-3L on average 0.61 (±0.77) for quality of life and 0.72 (±0.72) in HAQ for physical function.

The high consumption of health care resources by the older age group matches the health status. The average number of appointments was 7.74 (±8.40), and 24.16% was hospitalized in the last 12 months.

Regarding lifestyle habits, namely, in terms of alcohol intake and smoking habits, 36.43% of the individuals had reported a daily intake of alcohol beverages but only 5.39% were current smokers. Among the elderly, 43.65% of the subjects never consume alcohol and 66.35% of people aged 65 and above never smoked. Almost 60% of individuals above 65 years old do not engage in regular physical exercise, and around 70% of the Portuguese elderly sleep 6 or more hours per day.

Prevalence of Anxiety and Depression Symptoms in the Elderly {#S3-1}
------------------------------------------------------------

This study found 176 elderly out of 1,680 (10.48%) presenting anxiety symptoms (HADS-A ≥11), corresponding to a prevalence of 9.59% when weighted to Portuguese elderly population (Table [1](#T1){ref-type="table"}). The mean score for HADS-A was 5.04 (±3.74).

###### 

Prevalence of anxiety and depression in the Portuguese senior population by age group.

                  Elderly with anxiety symptoms (HADS-A ≥11)   Elderly with depression symptoms (HADS-D ≥11)
  --------------- -------------------------------------------- -----------------------------------------------
  Total           176 (9.59)                                   241 (11.77)
  **Age group**                                                
  65--69 y.o.     52 (12.38)                                   44 (7.29)
  70--74 y.o.     45 (7.86)                                    65 (11.33)
  75--79 y.o.     47 (8.99)                                    68 (15.16)
  80--84 y.o.     20 (7.96)                                    42 (14.85)
  ≥85 y.o.        12 (9.56)                                    22 (1.68)

*%, weighted percentage; HADS-A, Hospital Anxiety and Depression Scale---Anxiety subscale; HADS-D, Hospital Anxiety and Depression Scale-Depression subscale; y.o., year old*.

In terms of depression symptoms, figures rise to 241 (14.34% in the present sample), equivalent to a prevalence of 11.77% of the Portuguese elderly population (Table [1](#T1){ref-type="table"}). This population had a mean score for HADS-D of 5.27 (±4.07).

Sociodemographic, socioeconomic, lifestyle, and health-related characteristics of the Portuguese elderly population with and without anxiety symptoms are summarized in Table [2](#T2){ref-type="table"}.

###### 

Sociodemographic, socioeconomic, lifestyle, and health-related characteristics of the Portuguese elderly population with and without anxiety symptoms.

  Sociodemographic and socioeconomic characteristics                            Elderly without anxiety symptoms (HADS-A \<11)   Elderly with anxiety symptoms (HADS-A ≥11)   *p*-Value                                  Adjusted *p*-value                         
  ----------------------------------------------------------------------------- ------------------------------------------------ -------------------------------------------- ------------------------------------------ ------------------------------------------ ------------------------------------------
  **Age[\*](#tfn2){ref-type="table-fn"} (years)**                               74.24 (6.60)                                     73.96 (6.91)                                 0.059                                      0.131                                      
  Sex[\*](#tfn2){ref-type="table-fn"}                                           Female                                           768 (83.85)                                  140 (15.15)                                \<0.001[^†^](#tfn1){ref-type="table-fn"}   \<0.001[^†^](#tfn1){ref-type="table-fn"}
  Male                                                                          736 (95.44)                                      36 (4.56)                                                                                                                          
  NUTS II[\*](#tfn2){ref-type="table-fn"}                                       Norte                                            476 (89.88)                                  67 (10.12)                                 0.906                                      0.977
  Centro                                                                        378 (89.93)                                      49 (10.07)                                                                                                                         
  Lisboa e Vale do Tejo                                                         291 (90.56)                                      23 (9.44)                                                                                                                          
  Alentejo                                                                      95 (92.11)                                       11 (7.89)                                                                                                                          
  Algarve                                                                       57 (93.14)                                       3 (6.86)                                                                                                                           
  Região Autónoma dos Açores                                                    80 (93.04)                                       7 (6.96)                                                                                                                           
  Região Autónoma da Madeira                                                    127 (91.03)                                      16 (8.97)                                                                                                                          
  Education level[\*](#tfn2){ref-type="table-fn"}                               ≤4 years of education                            1,103 (88.55)                                156 (11.45)                                0.001[^†^](#tfn1){ref-type="table-fn"}     0.002[^†^](#tfn1){ref-type="table-fn"}
  \>4 years of education                                                        377 (95.98)                                      20 (4.02)                                                                                                                          
  Household income[\*](#tfn2){ref-type="table-fn"} (€)                          ≤500                                             384 (89.15)                                  58 (10.85)                                 0.430                                      0.411
  501--750                                                                      301 (91.75)                                      31 (8.25)                                                                                                                          
  751--1,000                                                                    152 (88.38)                                      16 (11.62)                                                                                                                         
  \>1,000                                                                       275 (94.52)                                      16 (5.48)                                                                                                                          
  Household composition                                                         1                                                374 (88.89)                                  55 (11.11)                                 0.388                                      0.900
  ≥2                                                                            1,130 (90.90)                                    121 (9.10)                                                                                                                         
  **Anthropometric data[\*](#tfn2){ref-type="table-fn"}**                                                                                                                                                                                                           
  BMI                                                                           Underweight                                      9 (84.23)                                    2 (15.77)                                  0.806                                      0.723
  Normal                                                                        397 (91.5)                                       47 (8.5)                                                                                                                           
  Overweight                                                                    647 (90.2)                                       59 (9.8)                                                                                                                           
  Obese                                                                         297 (91.32)                                      40 (8.68)                                                                                                                          
  **Lifestyle characteristics**                                                                                                                                                                                                                                     
  Alcohol intake[\*](#tfn2){ref-type="table-fn"}                                Never                                            630 (86.3)                                   102 (13.7)                                 0.002[^†^](#tfn1){ref-type="table-fn"}     0.054
  Daily intake                                                                  571 (94.7)                                       40 (5.5)                                                                                                                           
  Occasionally                                                                  300 (90.6)                                       34 (9.4)                                                                                                                           
  Smoke[\*](#tfn2){ref-type="table-fn"}                                         Never                                            969 (89.5)                                   145 (10.5)                                 0.480                                      0.344
  Past                                                                          449 (91.2)                                       25 (8.8)                                                                                                                           
  Present                                                                       85 (95.5)                                        6 (4.5)                                                                                                                            
  **No regular physical exercise[\*](#tfn2){ref-type="table-fn"}**              873 (91.0)                                       109 (9.0)                                    0.590                                      0.482                                      
  Sleep habits (h)                                                              \<6                                              250 (87.7)                                   38 (12.3)                                  \<0.001[^†^](#tfn1){ref-type="table-fn"}   0.003[^†^](#tfn1){ref-type="table-fn"}
  ≥6                                                                            586 (95.9)                                       31 (4.1)                                                                                                                           
  **Quality of life and physical function[\*\*](#tfn3){ref-type="table-fn"}**                                                                                                                                                                                       
  EQ5D (0--1)                                                                   0.66 ± 0.01                                      0.31 ± 0.02                                  \<0.001[^†^](#tfn1){ref-type="table-fn"}   \<0.001[^†^](#tfn1){ref-type="table-fn"}   
  HAQ score (0--3)                                                              0.63 ± 0.03                                      1.4 ± 0.06                                   \<0.001[^†^](#tfn1){ref-type="table-fn"}   \<0.001[^†^](#tfn1){ref-type="table-fn"}   
  Number of non-communicable diseases[\*](#tfn2){ref-type="table-fn"}           2.92 ± 1.95                                      4.76 ± 2.33                                  \<0.001[^†^](#tfn1){ref-type="table-fn"}   \<0.001[^†^](#tfn1){ref-type="table-fn"}   
   High blood pressure (Y/N)                                                    825 (87.8)                                       128 (12.2)                                   0.011[^†^](#tfn1){ref-type="table-fn"}     0.021[^†^](#tfn1){ref-type="table-fn"}     
   Diabetes (Y/N)                                                               341 (90.8)                                       47 (9.2)                                     0.808                                      0.874                                      
   High cholesterol level (Y/N)                                                 712 (89.3)                                       105 (10.8)                                   0.489                                      0.908                                      
   Pulmonar disease (Y/N)                                                       154 (82.6)                                       35 (17.4)                                    0.080                                      0.028[^†^](#tfn1){ref-type="table-fn"}     
   Cardiac disease (Y/N)                                                        370 (87.6)                                       67 (12.4)                                    0.127                                      0.104                                      
   Gastrointestinal diseases (Y/N)                                              380 (86.4)                                       72 (13.6)                                    0.037[^†^](#tfn1){ref-type="table-fn"}     0.121                                      
   Neurologic diseases (Y/N)                                                    106 (84.1)                                       22 (15.9)                                    0.080                                      0.256                                      
   Allergies (Y/N)                                                              313 (83.0)                                       57 (17.0)                                    0.011[^†^](#tfn1){ref-type="table-fn"}     0.015[^†^](#tfn1){ref-type="table-fn"}     
   Neoplasic disease (Y/N)                                                      128 (91.2)                                       15 (8.8)                                     0.732                                      0.600                                      
   Thyroid disease (Y/N)                                                        156 (80.9)                                       41 (19.1)                                    \<0.001[^†^](#tfn1){ref-type="table-fn"}   0.085                                      
   Hyperuricemia (Y/N)                                                          193 (89.1)                                       27 (10.9)                                    0.655                                      0.194                                      
   Rheumatic disease (Y/N)                                                      685 (84.0)                                       125 (16.0)                                   \<0.001[^†^](#tfn1){ref-type="table-fn"}   \<0.001[^†^](#tfn1){ref-type="table-fn"}   
  **Health resources consumption[\*\*](#tfn3){ref-type="table-fn"}**                                                                                                                                                                                                
  Was hospitalizes since last contact                                           343 (85.0)                                       60 (15.1)                                    0.016[^†^](#tfn1){ref-type="table-fn"}     0.003[^†^](#tfn1){ref-type="table-fn"}     
  Went to medical appointments in hospitals since last contact                  7.79 ± 0.36                                      13.9 ± 4.4                                   0.150                                      0.043[^†^](#tfn1){ref-type="table-fn"}     

*%, weighted percentage; NUTS II, Nomenclatura das Unidades Territoriais, level II; BMI, body mass index (kg/m^2^); €, euro; HADS-A, Hospital Anxiety and Depression Scale---Anxiety subscale; HAQ, Health Assessment Questionnaire (0--3); EQ5D, European Quality of Life questionnaire five dimensions three levels (0--1)*.

*^†^p-Value ≤ 0.05*.

*\*p-Value was adjusted for age, sex, and region*.

*[\*\*](#tfn3){ref-type="table-fn"}p-Value was adjusted for age, sex, region, and number of non-communicable diseases*.

Table [3](#T3){ref-type="table"} summarizes sociodemographic, socioeconomic, lifestyle, and health-related seven characteristics of the Portuguese elderly population with and without depression symptoms.

###### 

Sociodemographic, socioeconomic, lifestyle, and health-related characteristics of the Portuguese elderly population with and without depression symptoms.

  Sociodemographic and socioeconomic characteristics                            Elderly without depression symptoms (HADS-D \<11)   Elderly with depression symptoms (HADS-D ≥11)   *p*-Value       Adjusted *p*-value                         
  ----------------------------------------------------------------------------- --------------------------------------------------- ----------------------------------------------- --------------- ------------------------------------------ ------------------------------------------
  **Age[\*](#tfn5){ref-type="table-fn"} (years)**                                                                                   73.57 (6.51)                                    75.74 (7.23)    \<0.001[^†^](#tfn4){ref-type="table-fn"}   0.001[^†^](#tfn4){ref-type="table-fn"}
  Sex[\*](#tfn5){ref-type="table-fn"}                                           Female                                              747 (84.47)                                     161 (15.53)     \<0.001[^†^](#tfn4){ref-type="table-fn"}   \<0.001[^†^](#tfn4){ref-type="table-fn"}
                                                                                Male                                                692 (91.64)                                     80 (8.36)                                                  
  NUTS II[\*](#tfn5){ref-type="table-fn"}                                       Norte                                               463 (87.84)                                     80 (12.16)      0.020[^†^](#tfn4){ref-type="table-fn"}     0.084
                                                                                Centro                                              360 (85.41)                                     67 (14.59)                                                 
                                                                                Lisboa e Vale do Tejo                               281 (93.63)                                     33 (6.37)                                                  
                                                                                Alentejo                                            89 (87.2)                                       17 (12.8)                                                  
                                                                                Algarve                                             50 (86.89)                                      10 (13.11)                                                 
                                                                                Região Autónoma dos Açores                          76 (87.77)                                      11 (12.23)                                                 
                                                                                Região Autónoma da Madeira                          120 (85.62)                                     23 (14.38)                                                 
  Education level[\*](#tfn5){ref-type="table-fn"}                               ≤4 years of education                               1,046 (65.37)                                   213 (34.63)     \<0.001[^†^](#tfn4){ref-type="table-fn"}   \<0.001[^†^](#tfn4){ref-type="table-fn"}
                                                                                \>4 years of education                              373 (76.84)                                     24 (23.16)                                                 
  Household income[\*](#tfn5){ref-type="table-fn"} (€)                          ≤500                                                342 (80.53)                                     100 (19.47)     \<0.001[^†^](#tfn4){ref-type="table-fn"}   0.007[^†^](#tfn4){ref-type="table-fn"}
                                                                                501--750                                            291 (88.06)                                     41 (11.94)                                                 
                                                                                751--1,000                                          154 (96.26)                                     14 (3.74)                                                  
                                                                                \>1,000                                             271 (93.22)                                     20 (6.78)                                                  
  Household composition                                                         1                                                   347 (84.05)                                     82 (15.95)      0.009[^†^](#tfn4){ref-type="table-fn"}     0.161
                                                                                ≥2                                                  1,092 (89.58)                                   159 (10.42)                                                
  **Anthropometric data[\*](#tfn5){ref-type="table-fn"}**                                                                                                                                                                                      
  BMI                                                                           Underweight                                         9 (74.53)                                       2 (24.47)       0.293                                      0.245
                                                                                Normal                                              388 (89.99)                                     56 (10.01)                                                 
                                                                                Overweight                                          620 (89.98)                                     86 (10.02)                                                 
                                                                                Obese                                               284 (86.98)                                     53 (13.02)                                                 
  **Lifestyle characteristics**                                                                                                                                                                                                                
  Alcohol intake[\*](#tfn5){ref-type="table-fn"}                                Never                                               579 (83.2)                                      153 (16.8)      \<0.001[^†^](#tfn4){ref-type="table-fn"}   0.001[^†^](#tfn4){ref-type="table-fn"}
                                                                                Daily intake                                        553 (91.7)                                      58 (8.3)                                                   
                                                                                Occasionally                                        304 (92.1)                                      30 (7.9)                                                   
  Smoke[\*](#tfn5){ref-type="table-fn"}                                         Never                                               926 (85.8)                                      188 (14.2)      0.001[^†^](#tfn4){ref-type="table-fn"}     0.154
                                                                                Past                                                434 (93.0)                                      40 (7.0)                                                   
                                                                                Present                                             78 (90.2)                                       13 (9.8)                                                   
  No regular physical exercise[\*](#tfn5){ref-type="table-fn"}                                                                      807 (85.0)                                      175 (15.0)      \<0.001[^†^](#tfn4){ref-type="table-fn"}   0.001
  Sleep habits (h)                                                              \<6                                                 241 (86.1)                                      47 (13.9)       0.008[^†^](#tfn4){ref-type="table-fn"}     0.048[^†^](#tfn4){ref-type="table-fn"}
                                                                                ≥6                                                  528 (92.1)                                      59 (7.9)                                                   
  **Quality of life and physical function[\*\*](#tfn6){ref-type="table-fn"}**                                                                                                                                                                  
  EQ5D (0--1)                                                                                                                       0.67 ± 0.02                                     0.32 ± 0.02     \<0.001[^†^](#tfn4){ref-type="table-fn"}   \<0.001[^†^](#tfn4){ref-type="table-fn"}
  HAQ score (0--3)                                                                                                                  0.61 ± 0.03                                     1.38 ± 0.59     \<0.001[^†^](#tfn4){ref-type="table-fn"}   \<0.001[^†^](#tfn4){ref-type="table-fn"}
  Number of non-communicable diseases                                                                                               2.95 ± 1.93                                     4.36 ± 2.70     \<0.001[^†^](#tfn4){ref-type="table-fn"}   \<0.001[^†^](#tfn4){ref-type="table-fn"}
  High blood pressure (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                         804 (87.2)                                      149 (12.76)     0.093                                      0.121
  Diabetes (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                                    315 (84.8)                                      73 (15.2)       0.039[^†^](#tfn4){ref-type="table-fn"}     0.022[^†^](#tfn4){ref-type="table-fn"}
  High cholesterol level (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                      688 (86.0)                                      129 (14.0)      0.013[^†^](#tfn4){ref-type="table-fn"}     0.056
  Pulmonar disease (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                            150 (82.9)                                      39 (17.1)       0.023[^†^](#tfn4){ref-type="table-fn"}     0.038[^†^](#tfn4){ref-type="table-fn"}
  Cardiac disease (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                             347 (83.6)                                      90 (16.5)       0.001[^†^](#tfn4){ref-type="table-fn"}     0.015[^†^](#tfn4){ref-type="table-fn"}
  Gastrointestinal diseases (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                   367 (63.6)                                      85 (36.4)       0.019[^†^](#tfn4){ref-type="table-fn"}     0.019[^†^](#tfn4){ref-type="table-fn"}
  Neurologic diseases (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                         102 (80.5)                                      26 (19.5)       0.028[^†^](#tfn4){ref-type="table-fn"}     0.009[^†^](#tfn4){ref-type="table-fn"}
  Allergies (Y/N)                                                                                                                   312 (87.9)                                      58 (12.1)       0.074                                      0.970
  Neoplasic disease (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                           122 (87.3)                                      21 (12.7)       0.686                                      0.676
  Thyroid disease (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                             157 (80.6)                                      40 (19.4)       0.001[^†^](#tfn4){ref-type="table-fn"}     0.061
  Hyperuricemia (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                               181 (83.2)                                      39 (16.8)       0.010[^†^](#tfn4){ref-type="table-fn"}     0.009[^†^](#tfn4){ref-type="table-fn"}
  Rheumatic disease (Y/N)[\*](#tfn5){ref-type="table-fn"}                                                                           649 (82.9)                                      161 (17.1)      \<0.001[^†^](#tfn4){ref-type="table-fn"}   \<0.001[^†^](#tfn4){ref-type="table-fn"}
  **Health resources consumption[\*\*](#tfn6){ref-type="table-fn"}**                                                                                                                                                                           
  Was hospitalizes since last contact                                                                                               334 (86.6)                                      69 (13.4)       0.226                                      0.043[^†^](#tfn4){ref-type="table-fn"}
  Went to medical appointments in hospitals since last contact                                                                      8.170 ± 0.634                                   8.961 ± 1.092   0.455                                      0.376

*%, weighted percentage; NUTS II, Nomenclatura das Unidades Territoriais, level II; BMI, body mass index; €, euro; HADS-D, Hospital Anxiety and Depression Scale---Depression subscale; HAQ, Health Assessment Questionnaire (0--3); EQ5D, European Quality of Life questionnaire five dimensions three levels (0--1)*.

*^†^p-Value ≤ 0.05*.

*\*p-Value was adjusted for age, sex, and region*.

*\*\*p-Value was adjusted for age, sex, region, and number of non-communicable diseases*.

Anxiety and Depression Symptoms and Physical Function in Seniors {#S3-2}
----------------------------------------------------------------

Seniors with anxiety have a higher probability to have reported, even after the adjustment for sex, age, region, and number of non-communicable diseases, higher levels of physical disability (OR = 3.10; 96% CI 2.12--4.52).

Similar results were found for depression symptoms and seniors with depression have reported higher levels of physical disability (OR = 3.08, 95% CI 2.29--4.14).

Anxiety and Depression Symptoms and Quality of Life in the Elderly {#S3-3}
------------------------------------------------------------------

In terms of quality of life (EQ-5D-3L score), seniors with anxiety have a higher probability to report lower levels of quality of life (OR = 0.03, 95% CI 0.01--0.09). These results were found after the adjustment for sex, age, region, and number of non-communicable diseases.

Multivariable analyses adjusting to sex, age, region, and number of non-communicable diseases also showed that seniors with depression symptoms have a higher probability to have reported lower levels of quality of life (OR = 0.03; 95% CI 0.01--0.06).

Anxiety and Depression Symptoms and Health-care Resources Consumption in the Elderly {#S3-4}
------------------------------------------------------------------------------------

Logistic regression adjusted to sex, age, region, and number of non-communicable diseases stressed that seniors with anxiety symptoms have a higher probability to have reported higher number of hospitalizations in the previous 12 months (OR = 2.53, 95% CI 1.37--4.67) and have reported a higher number of medical appointments in the previous 12 months.

Seniors with depression symptoms have also a higher probability to have reported higher number of hospitalizations in the previous 12 months (OR = 1.55, 95% CI 1.01--2.35). In terms of number of medical appointments in the previous 12 months, there is no significant difference between elderly with and without depressive symptoms.

Sociodemographic, Lifestyles, and Health Factors Independently Associated with Anxiety in Seniors {#S3-5}
-------------------------------------------------------------------------------------------------

Multivariable logistic regression, including all previous significant independent variables, showed that being a woman (OR = 2.77, 95% CI 1.53--5.00) and have a low educational level (OR = 2.30, 95% CI 1.22--4.36) were significantly associated with anxiety symptoms. Regarding self-reported non-communicable chronic diseases, our results showed that only allergies (OR = 2.02, 95% CI 1.14--3.55) and rheumatic disease (OR = 2.92, 95% CI 1.74--4.90) were statistically significant associated with anxiety symptoms (Table [4](#T4){ref-type="table"}).

###### 

Factors associated with anxiety symptoms in seniors.

                                    Anxiety symptoms (yes/no)                                              
  --------------------------------- --------------------------- ------------ --------- ------ ------------ ---------
  **Gender**                                                                                               
  Male                              Ref.                                                                   
  Female                            3.74                        2.12--6.62   0.000     2.77   1.53--5.00   0.001
  Age (years)                       0.98                        0.94--1.02   0.371     0.96   0.92--1.00   0.078
  **NUTS II**                                                                                              
  Norte                             Ref.                                               Ref.                
  Centro                            0.99                        0.63--1.57   0.982     0.98   0.60--1.60   0.939
  Lisboa                            0.92                        0.29--3.00   0.897     0.97   0.37--2.54   0.949
  Alentejo                          0.76                        0.37--1.57   0.462     0.79   0.36--1.73   0.553
  Algarve                           0.65                        0.18--2.42   0.525     0.93   0.23--3.78   0.918
  Azores                            0.66                        0.28--1.58   0.356     1.14   0.41--3.18   0.796
  Madeira                           0.87                        0.46--1.66   0.683     0.91   0.48--1.75   0.785
  Live alone (Y/N)                  1.25                        0.75--2.07   0.389                         
  **Level of education**                                                                                   
  ≤4 years                          3.09                        1.72--5.54   0.000     2.30   1.22--4.36   0.010
  \>4 years                         Ref.                                                                   
  **BMI**                                                                                                  
  Underweight                       Ref.                                                                   
  Normal                            0.50                        0.10--2.45   0.390                         
  Overweight                        0.58                        0.11--3.05   0.521                         
  Obese                             0.51                        0.10--2.52   0.407                         
  **Alcohol intake**                                                                                       
  Never                             Ref.                                                                   
  Daily intake                      0.35                        0.20--0.62   \<0.001                       
  Occasionally                      0.65                        0.33--1.30   0.224                         
  **Smoke**                                                                                                
  Never                             Ref.                                                                   
  Past                              0.82                        0.33--2.06   0.680                         
  Present                           0.40                        0.15--1.06   0.066                         
  No regular physical exercise      0.85                        0.48--1.53   0.590                         
  High blood pressure (Y/N)         2.03                        1.18--3.50   0.011                         
  Diabetes (Y/N)                    0.94                        0.56--1.58   0.808                         
  High cholesterol level (Y/N)      1.23                        0.69--2.20   0.489                         
  Pulmonar disease (Y/N)            1.64                        0.94--2.85   0.080                         
  Cardiac disease (Y/N)             1.50                        0.89--2.52   0.127                         
  Gastrointestinal diseases (Y/N)   1.80                        1.03--3.13   0.039                         
  Neurologic diseases (Y/N)         1.85                        0.93--3.67   0.080                         
  Allergies (Y/N)                   2.43                        1.23--4.79   0.011     2.02   1.14--3.55   0.015
  Neoplasic disease (Y/N)           0.89                        0.46--1.72   0.732                         
  Thyroid disease (Y/N)             2.51                        1.50--4.20   \<0.001                       
  Hyperuricemia (Y/N)               1.13                        0.65--1.98   0.655                         
  Rheumatic disease (Y/N)           4.36                        2.65--7.16   \<0.001   2.92   1.74--4.90   \<0.001

*HADS-A, Hospital Anxiety and Depression Scale---Anxiety subscale; OR, odds ratio; CI, confidence interval; HAQ, Health Assessment Questionnaire (0--3); EQ5D, European Quality of Life questionnaire five dimensions three levels (0--1); BMI, body mass index*.

*^†^*p*-Value ≤ 0.05; GoF (*p* = 0.287)*.

Sociodemographic, Lifestyles, and Health Factors Independently Associated with Depression in Seniors {#S3-6}
----------------------------------------------------------------------------------------------------

All previous significant independent variables were included in a multivariable logistic regression to depression symptoms. In this analysis, low educational level (OR = 2.40, 95% CI 1.41--4.09), physical inactivity (OR = 1.64, 95% CI 1.11--2.42), and alcohol intake on a daily (OR = 0.54, 95% CI 0.35--0.83) and occasionally basis (OR = 0.49, 95% CI 0.29--0.84) were protectors of depression (were associated with low risk of depression symptoms) (Table [5](#T5){ref-type="table"}).

###### 

Factors associated with depression symptoms in seniors.

                                    Depression symptoms (yes/no)                                              
  --------------------------------- ------------------------------ ------------ --------- ------ ------------ ---------
  **Gender**                                                                                                  
  Male                              Ref.                                                                      
  Female                            2.02                           1.42--2.85   \<0.001   1.30   0.87--1.94   0.207
  Age                               1.05                           1.02--1.07   \<0.001   1.02   1.00--1.05   0.064
  **NUTS II**                                                                                                 
  Norte                             Ref.                                                                      
  Centro                            1.23                           0.84--1.82   0.289     1.11   0.73--1.70   0.607
  Lisboa                            0.49                           0.29--0.84   0.009     0.51   0.28--0.96   0.037
  Alentejo                          1.06                           0.58--1.94   0.849     1.18   0.64--2.18   0.603
  Algarve                           1.09                           0.49--2.44   0.834     0.25   0.55--2.83   0.590
  Azores                            1.01                           0.49--2.04   0.985     0.56   0.75--3.26   0.237
  Madeira                           1.21                           0.70--2.11   0.492     1.20   0.66--2.18   0.547
  Live alone (Y/N)                  1.63                           1.13--2.35   0.009                         
  **Level of education (years)**                                                                              
  ≤4                                3.57                           2.16--5.92   \<0.001   2.40   1.41--4.09   0.001
  \>4                               Ref.                                                                      
  **BMI**                                                                                                     
  Underweight                       Ref.                                                                      
  Normal                            0.32                           0.06--1.74   0.189                         
  Overweight                        0.33                           0.06--1.72   0.186                         
  Obese                             0.44                           0.08--2.30   0.334                         
  **Alcohol intake**                                                                                          
  Never                             Ref.                                                                      
  Daily intake                      0.45                           0.30--0.66   \<0.001   0.54   0.35--0.83   0.005
  Occasionally                      0.42                           0.26--0.70   0.001     0.49   0.29--0.84   0.009
  **Smoke**                                                                                                   
  Never                             Ref.                                                                      
  Past                              0.46                           0.30--0.70   \<0.001                       
  Present                           0.66                           0.30--1.44   0.300                         
  No regular physical exercise      2.07                           1.44--2.98   \<0.001   1.64   1.11--2.42   0.013
  High blood pressure (Y/N)         1.35                           0.95--1.92   0.094                         
  Diabetes (Y/N)                    1.50                           1.02--2.21   0.040                         
  High cholesterol level (Y/N)      1.53                           1.09--2.14   0.014                         
  Pulmonar disease (Y/N)            1.71                           1.07--2.73   0.024                         
  Cardiac disease (Y/N)             1.83                           1.27--2.64   0.001                         
  Gastrointestinal diseases (Y/N)   1.56                           1.07--2.27   0.020                         
  Neurologic diseases (Y/N)         1.97                           1.06--3.63   0.031                         
  Allergies (Y/N)                   1.07                           0.72--1.57   0.741                         
  Neoplasic disease (Y/N)           1.12                           0.65--1.94   0.686                         
  Thyroid disease (Y/N)             2.01                           1.31--3.08   0.001                         
  Hyperuricemia (Y/N)               1.74                           1.14--2.65   0.011                         
  Rheumatic disease (Y/N)           2.94                           2.04--4.23   \<0.001   2.12   1.45--3.09   \<0.001

*HADS-D, Hospital Anxiety and Depression Scale-Depression subscale; OR, odds ratio; CI, confidence interval; HAQ, Health Assessment Questionnaire (0--3); EQ5D, European Quality of Life questionnaire five dimensions, three levels (0--1); BMI, body mass index*.

*Household composition: number of people that live in the house of the participant, including himself/herself*.

*^†^*p*-Value ≤ 0.05; GoF (*p* = 0.04056)*.

Discussion {#S4}
==========

This study showed a prevalence of 9.6% of anxiety symptoms among the Portuguese with 65 or more years old. This number is lower than the ones found in international studies over Australia, European, and American countries ([@B24]). These authors referred prevalence of significant anxiety symptoms between 15 and 52% in the elderly living in the community. Almost 10 years ago, an epidemiological study in Portugal, whose data were collected between 2008 and 2009, found the prevalence of generalized anxiety disorder in people over 65 years of age at 2.6% and the prevalence of any anxiety disorders 20% for the same age group ([@B25]).

Regarding depression, the estimated prevalence is of 11.8% for the Portuguese elderly living in the community, in line with the result of 12% for Major Depressive Disorder of the National Epidemiologic Study of Mental Health ([@B25]). In the Netherlands, however, depressive symptoms had a prevalence of 24% for older adults---55 years old and older ([@B26]), and Castro-Costa et al. exposed a prevalence of depressive symptoms ranging from 33% in France, Italy, and Spain, to 18--19%, in Sweden, Denmark, Netherlands, Germany, Austria, and Switzerland in adults over 50 years old ([@B6]).

Although the presented figures may suggest that Portuguese elderly are less anxious and depressed than other peoples in Europe and around the globe, one should be very careful when comparing these numbers. There are core discrepancies regarding methods of data collection, different instruments of assessing depression and anxiety, different nosological entities considered (major depression disorder, minor depression disorder, generalized anxiety disorder vs symptoms of depression and anxiety), and finally different age groups cutoffs (≥50 and ≥55 vs ≥65).

As Byrne stressed differences in anxiety prevalence rates may be due to differences among populations, but also to differences in assessment tools and algorithms used for diagnosis such as State Trait Anxiety Inventory and Anxiety Disorder Scale ([@B27]). Some studies use the hierarchical approach to diagnosis, which may lead to lower prevalence by excluding individuals with diagnostic criteria that also have criteria for diagnosing other higher disorders in the hierarchy ([@B3]).

Our study demonstrates a close relationship between physical function and anxiety and depression showing that seniors with lower physical function are more likely to report anxiety and/or depression symptoms. Lenze and collaborators performed a literature review on the association of late life depression and anxiety with physical disability. Their findings indicated that depression was a risk factor for disability, but also in the other way, being disability a risk factor for depression ([@B28]). Brenes and colleagues studied the influence of anxiety on the progression of physical disability in a community-based observational work, concluding that, after adjusting for confounders, anxiety continued to predict the development of disability in activities of daily living ([@B29]).

In terms of quality of life, our results suggest that seniors with anxiety and/or depression are more likely to have reported lower levels of quality of life. Sivertsen and colleagues, in their review article of 74 studies, concluded the same, demonstrating that depressed older people had poor global quality of life than non-depressed individuals. They added that this association was stable over time and independently of how quality of life was measured ([@B30]). Brenes also considered anxiety in relation to quality of life, and her conclusions were similar: anxiety was significantly associated with all domains of quality of life, and as severity of anxiety symptoms increased, quality of life decreased ([@B31]). Having very low income was also related to higher depression. This is in line with what Valvanne and collaborators defended in their elderly population-based study in Finland ([@B32]). McCall and colleagues findings in USA also corroborated the conclusions that related low income to higher scores of depression ([@B33]).

To assess determinants for anxiety and depression, a multivariable logistic regression, using socioeconomic factors and chronic diseases was developed.

The results considering the outcome as a binary variable "Anxiety disorders (Yes/No)" showed that being a woman, having less than 5 years of education, having a rheumatic disease and allergies were factors highly associated to higher scores of the anxiety diagnosis in Portuguese elders. Beekman and colleagues had already pointed sex and education level out as relevant to understand anxiety in their study with LASA cohort data ([@B34]).

Although other studies found a significant higher rate of anxiety in women with 55 or more years old ([@B35]), this was not found in our population.

A global model using multivariable logistic regression was also used to capture the framework of factors related to depression in Portuguese elderly, level of education, physical inactivity, alcohol intake on a daily and occasionally basis, and rheumatic disease should be taken into account when considering depression in this population.

This is in line with the literature supporting that physical activity is associated with lower levels of depression ([@B36]) Also, several studies suggest that lower education is associated with depression ([@B37]--[@B39]).

Regarding alcohol intake, the results found denote that the daily or occasional consumption of alcoholic beverages decreases the probability of reporting depression among seniors. Although this result can be unsettling at first glance, it is important to retain that this study assessed consumption frequency, rather than type or quantity. In the literature, several studies associate alcohol misuse or alcoholism with higher levels of depression ([@B40], [@B41]). That is, however, a different matter.

Although literature often expresses a relationship between anxiety and/or depression and diabetes ([@B42]), pulmonary ([@B43]), and neoplasic diseases ([@B44]), these associations were not confirmed in Portuguese senior population. Our study confirms, however, conclusions of previous studies on rheumatic diseases ([@B11], [@B45], [@B46]) stressing their important association with both anxiety and depression, as well as the relationship between allergies and anxiety, patent in the literature ([@B47]).

Interestingly, the female sex is also described in literature as an important determinant of depression ([@B46], [@B48]). In our study, it was strongly significant even with multivariable analyses with single factors separately, such as non-communicable chronic diseases, quality of life, or function. But within a global model including all significant variables for depression, it loses its previous relevance.

Regarding age, Alameda County Study demonstrated a raise of depression prevalence with age ([@B49]). But multivariable analyses showed that the effect of age was related to physical health problems and disability associated with aging. Several studies concluded the same way, indicating that although depression prevalence increases with age, it should be due to age-related factors than age itself ([@B50], [@B51]).

Study limitations should be considered when interpreting results. Being cross-sectional, this analysis does not allow to draw conclusions about the effects of causality between the variables and the chronological order of the events.

Although Breeman defended HADS being used for clinical and non-clinical population ([@B52]), the use of a specific instrument to assess anxiety and depression in this particular age group is arguable.

Despite of what has been referred, several strengths related to both internal and external validity should be pointed out. Data come from large, nationally representative sample of the Portuguese elder population followed since 2011, allowing its generalization for the age group in our country. It should also be noted that data were collected by a team of 10 interviewers who were extensively and properly trained, whose proceedings were standardized, and regular and rigorously monitored to assess quality and reduce bias.

In conclusion, key findings of this study are as follows: (1) Portuguese elderly population have prevalence of anxiety and depression around 10 and 12%, respectively; (2) anxiety and depression are associated to different factors; (3) health-related quality of life and physical function play an important role in depression and anxiety; and (4) level of education distinguishes senior in terms of anxiety and depression.
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